MedTrace Logo

Radiomics in Rectal Cancer

NCT05331040 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 350

Last updated 2022-04-29

No results posted yet for this study

Summary

This retrospective study aims to investigate whether initial imaging characteristics of rectal cancer on Magnetic Resonance Imaging (MRI) correlate with the underlying tumour pathology and oncological outcomes such as response to treatment. Using radiomic features, calculated using new high throughput analysis of previously acquired imaging, a statistically robust prognostic model will be created with the overall aim of developing imaging biomarkers.

Conditions

Interventions

DIAGNOSTIC_TEST

MRI

Radiomic analysis of newly diagnosed rectal cancers

Sponsors & Collaborators

  • Industrial centre for Artificial intelligence Research

    collaborator UNKNOWN

  • Roland Sutton Academic Trust

    collaborator UNKNOWN

  • Innovate UK

    collaborator OTHER_GOV

  • University of Aberdeen

    collaborator OTHER

  • NHS Grampian

    lead OTHER_GOV

Principal Investigators

  • Rosalind Mitchell-Hay · NHS Grampian & University of Aberdeen

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2023-03-31
Completion
2025-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05331040 on ClinicalTrials.gov